openPR Logo
Press release

Opioid Use Disorder Market Poised to Achieve Significant Growth by 2031 | Indivior PLC, Titan Pharmaceuticals Inc., BioDelivery Sciences International

03-08-2022 02:47 PM CET | Health & Medicine

Press release from: insightSLICE

Opioid Use Disorder Industry- insightSLICE

Opioid Use Disorder Industry- insightSLICE

insightSLICE, a industry research firm published latest report on the "Opioid Use Disorder Industry by size, by share, by trends, by application and forecast to 2031" providing a better understanding of the overall domain analytics and measures. Trending technology, drivers, regional shares, statistics, projections, manufacturers, and equipment vendors are all included in the report.

The global opioid use disorder market size was estimated to be US$ 2.52 billion in 2020 and is expected to reach US$ 6.2 billion by 2031 at a CAGR of 8.5%.

The report estimates the overall global Opioid Use Disorder industry size, share, trends by analyzing historical data and prospects from 2021 to 2031. The research provides an understanding of domain performance across historic years, present year, and future projections. The study provides a picture of the domains foundation and framework. The assessment of segments' shares and growth helps understand the domains position.

Request FREE Sample Report of Opioid Use Disorder Industry@ https://www.insightslice.com/request-sample/844

The Report Considers The Following Important Parameters:

- Global Opioid Use Disorder industry sizing (value & volume) by key business segments and potential and emerging countries/geographies
- Prevalent trends
- Consumers' preferences, vendor, and supplier landscape
- Projected growth opportunities
- Industry challenges and constraints
- Geographic distribution
- Other developments

Competitive Analysis:

According to the review duration, the key companies operating in the global Opioid Use Disorder industry are actively expanding boundaries and portfolios. The document provides the latest updated list of several business strategies, including mergers, acquisitions, partnerships, product launches, production unit expansions, and collaborations adopted by these major global players.

Following companies are key players in the Opioid Use Disorder industry: Indivior PLC, Titan Pharmaceuticals, Inc., BioDelivery Sciences International, Inc., Alkermes, Inc., Omeros Corporation, Camurus, Hikma Pharmaceuticals PLC, and others.

Request To Get Discount on this Opioid Use Disorder-industry report:

The industry's positive and restrictive factors for global and regional growth are also highlighted in the report. It then describes the opportunities & challenges and drivers & restraints that have a major impact on the growth rate of the global Opioid Use Disorder industry. The report includes a detailed analysis of the domain, as well as enabling technologies, current trends, and obstacles, as well as a self-governing perspective, deployment models, operator-specific situations, and supply chain.

The research contains information on product cost, revenue, capability, manufacture, supply, demand, domain development rate, and outlook, among other things. This research report focuses on domainvolume and value at the regional level and company trends from a global perspective. A better perspective and understanding of the global Opioid Use Disorder industry is given to the target audience. The newly added report is a complete guide to understanding various factors that play a crucial role in growth progression.

(You may enquire about a report quote OR available discount offers to our sales team before purchase.)Need More Information? Inquire more about this report before purchase @ https://www.insightslice.com/speak-to-analyst/844

Segmentation Overview:

Based on drug class

Buprenorphine
Methadone
Naltrexone
Others

Based on route of administration

Oral
Parenteral
Others

Based on distribution channel

Hospital Pharmacies
Retail Pharmacies & Stores
Online Pharmacies
Others

Regional industry analysis can be represented as follows:

North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and the Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and the rest of South America)
The Middle East and Africa (Saudi Arabia, United Arab Emirates, Egypt, South Africa, and the Rest of the Middle East and Africa)

From a geographic segmentation perspective, the report focuses on the regions that have a significant effect on the overall domain value. A clear understanding of the domain growth rate and status over the forecast period from 2021 to 2031 is provided in the report.

Reasons To Purchase This Report:

• Quick and timely customer support for domestic as well as international clients
• Expert and experienced research analysts in terms of marketing research approaches
• We use the most recent and authentic marketing research tools and techniques to assess the statistical numbers
• Current and way forward for global Opioid Use Disorder industry outlook within the developed and emerging domains
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, industry shares, and techniques that are employed by the most important industry players

* Get 10% Discount on Your Direct Purchase *
You Can Purchase Complete Report@ https://www.insightslice.com/buy-now/844

Contact:
Alex
alex@insightslice.com
+1 (707) 736 6633
422 Lark Center # 1001, Santa Rosa,
California - 95403-1408, USA

About Us:

We are a team of research analysts and management consultants who share a common vision to help individuals and organizations achieve their short-term and long-term strategic goals by expanding high-quality research services. insightSLICE was established to support mature companies, start-ups and non-profit organizations in various industries, including packaging, automotive, healthcare, chemicals and materials, industrial automation, consumer products, electronics and semiconductors, IT and telecommunications, and energy. Our internally experienced team of analysts has extensive experience in the research industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Opioid Use Disorder Market Poised to Achieve Significant Growth by 2031 | Indivior PLC, Titan Pharmaceuticals Inc., BioDelivery Sciences International here

News-ID: 2573004 • Views:

More Releases from insightSLICE

Antivirals Market is experiencing boost at an infinite speed By 2032 | AbbVie Inc, Aurobindo Pharma Limited, Bristol-Myers Squibb
Antivirals Market is experiencing boost at an infinite speed By 2032 | AbbVie In …
The global antivirals market size was estimated to be US$ 47.7 billion in 2021 and is expected grow at a CAGR of 3.6% between 2023 to 2032. Global Antivirals Market Size, Status, and Forecast for the 2023-2032. Comprehensive analysis has been compiled to supply the foremost up-to-date data on key aspects of the market. This research report covers major aspects of the Antivirals industry, as well as drivers, restraints, PESTLE analysis, historical and current trends, regulative situations, and
Biobanks Market Will Generate Booming Growth Opportunities to 2032 | Avantor, BioCision, Biovault Family
Biobanks Market Will Generate Booming Growth Opportunities to 2032 | Avantor, Bi …
The global biobanks market size was estimated to be US$ 65 billion in 2021 and is expected grow at a CAGR of 4.5% between 2023 to 2032. Global Biobanks Market Size, Status, and Forecast for the 2023-2032. Comprehensive analysis has been compiled to supply the foremost up-to-date data on key aspects of the market. This research report covers major aspects of the Biobanks industry, as well as drivers, restraints, PESTLE analysis, historical and current trends, regulative
Airway Management Devices Market Sales Revenue Strategies Insights 2022-2032 | GE Healthcare, Medtronic plc, Koninklijke Philips N.V
Airway Management Devices Market Sales Revenue Strategies Insights 2022-2032 | G …
The global airway management devices market size was estimated to be US$ 1.5 billion in 2021 and is expected grow at a CAGR of 7.2% between 2023 to 2032.  Global Airway Management Devices Market Size, Status, and Forecast for the 2023-2032. Comprehensive analysis has been compiled to supply the foremost up-to-date data on key aspects of the market. This research report covers major aspects of the Airway Management Devices industry, as well as drivers, restraints, PESTLE
Pharmaceutical Isolator Market to Exhibit Fastest Growth in Future Scope 2022-2032 | Skan AG, COMECER S.p.A, Robert Bosch GmbH
Pharmaceutical Isolator Market to Exhibit Fastest Growth in Future Scope 2022-20 …
The global pharmaceutical isolator market size was estimated to be US$ 5.75 billion in 2021 and is expected grow at a CAGR of 5.4% between 2023 to 2032. Global Pharmaceutical Isolator Market Size, Status, and Forecast for the 2023-2032. Comprehensive analysis has been compiled to supply the foremost up-to-date data on key aspects of the market. This research report covers major aspects of the Pharmaceutical Isolator industry, as well as drivers, restraints, PESTLE analysis, historical and

All 5 Releases


More Releases for Opioid

Rising Opioid Use For Pain Management Fuels Growth In Opioid-Induced Constipatio …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Opioid-Induced Constipation Treatment Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for treatment of opioid-induced constipation has seen a substantial growth recently. It is expected to escalate from a solid $1.78 billion in 2024 to an impressive $1.9 billion in 2025, exhibiting
Growing Number Of Opioid Addiction Cases: Strategic Insights Driving Opioid Use …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Opioid Use Disorder (OUD) Market Size By 2025? The market size for opioid use disorder (OUD) has experienced a quick expansion in the past few years. The growth is projected to rise from $3.96 billion in 2024 to $4.39 billion in 2025, boasting a compound
Key Influencer in the Opioid-Induced Constipation Treatment Market 2025: Rising …
What combination of drivers is leading to accelerated growth in the opioid-induced constipation treatment market? The rise in opioid administration for cancer and non-cancer pain is expected to drive the growth of the opioid-induced constipation (OIC) treatment market. Opioids are commonly used for managing moderate to severe pain, but they can cause constipation. OIC treatments are vital for improving the quality of life for patients on opioids, allowing them to maintain
Top Factor Driving Opioid Use Disorder (OUD) Market Growth in 2025: Growing Numb …
How Are the key drivers contributing to the expansion of the opioid use disorder (oud) market? The rise in instances of opioid dependency is set to fuel the expansion of the opioid use disorder (OUD) market. Opioid dependency defines a health concern marked by habitual and uncontrolled opioid consumption which negatively impacts health. These opioids can generate feelings of bliss and relief from pain, but continued usage often results in tolerance
What's Driving the Opioid-Induced Constipation Treatment Market 2025-2034: Risin …
What Are the Projections for the Size and Growth Rate of the Opioid-Induced Constipation Treatment Market? The market size for treatments of constipation caused by opioids has seen robust growth lately. The forecasted growth indicates an increase from $1.78 billion in 2024 to $1.9 billion in 2025, representing a compound annual growth rate (CAGR) of 7.0%. This past growth is associated with a growing elderly population, individualized treatments for OIC, the
MEDICAL MARIJUANA AND THE OPIOID CRISIS
Marijuana from the Cannabis plant is classified as a psychoactive drug used for medical or recreational purposes. Although it has been used for decades, in the U.S., it is still illegal under federal law to use and possess marijuana. Get PDF Sample Brochure of this report at: https://decisionmarketreports.com/request-sample/1247622 Nevertheless, at the state level, policies regarding the medical and recreational use of Cannabis vary greatly, and in many states conflict significantly with federal